GH Research (GHRS) Cash & Equivalents (2020 - 2025)

GH Research's Cash & Equivalents history runs 6 years deep, the most recent figure standing at $100.8 million for Q4 2025.

• In Q4 2025, Cash & Equivalents changed 0.0% year-over-year to $100.8 million; the TTM figure through Dec 2025 stood at $100.8 million (changed 0.0% YoY), while the FY2025 annual figure was $100.8 million, changed 0.0% from the prior year.
• Cash & Equivalents was $100.8 million for Q4 2025 at GH Research, roughly flat from $100.8 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $280.7 million in Q3 2021 to a low of $5.9 million in Q1 2021.
• Historically, Cash & Equivalents has averaged $144.5 million across 5 years, with a median of $100.8 million in 2024.
• The sharpest annual moves came in 2021 and 2024: Cash & Equivalents soared 56274.5% in 2021, then sank 53.31% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $276.8 million in 2021, then plunged by 40.04% to $166.0 million in 2022, then plunged by 52.75% to $78.4 million in 2023, then advanced by 28.53% to $100.8 million in 2024, then changed by 0.0% to $100.8 million in 2025.
• The last three Cash & Equivalents figures came in at $100.8 million (Q4 2025), $100.8 million (Q3 2025), and $100.8 million (Q2 2025), per Business Quant data.